Pfizer, Johnson drop tests for new Alzheimer drug
• The Raw Story.comPfizer and Johnson & Johnson said Monday they had given up tests of a new therapy to treat Alzheimer’s disease, saying the treatment did not measure up to expectations.
Streaming Live from LRN.fm
Streaming Live from LRN.fm
Pfizer and Johnson & Johnson said Monday they had given up tests of a new therapy to treat Alzheimer’s disease, saying the treatment did not measure up to expectations.
